Mustang Bio Inc (MBIO)

Jun 17, 2025

Mustang Bio (NASDAQ:MBIO) Shares Down 5.1% – What’s Next? - Defense World

Jun 17, 2025

Jun 06, 2025

ASCO: Kite’s Glioblastoma CAR-T Highlights Solid Tumor Progress - insights.citeline.com

Jun 06, 2025

Jun 05, 2025

Pre-market Movers: LIMN, KRON, HSDT, CBUS... - RTTNews

Jun 05, 2025

Jun 05, 2025

Why MongoDB Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket - Benzinga

Jun 05, 2025

Jun 03, 2025

CAR T Cell Therapy Market Projected to Witness Massive Growth - openPR.com

Jun 03, 2025

Jun 02, 2025

Layoff Tracker: Keros Cuts 45% of Workforce Along With Pulmonary Hypertension Drug - BioSpace

Jun 02, 2025

May 26, 2025

Mustang Bio Reports Improved Financials Amid Strategic Adjustments - TipRanks

May 26, 2025

May 24, 2025

Mustang Bio (NASDAQ:MBIO) Rating Increased to Hold at Wall Street Zen - Defense World

May 24, 2025

May 15, 2025

Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewswire

May 15, 2025

May 12, 2025

Asia-Pacific Personalized Cell Therapy Market Report - openPR.com

May 12, 2025

May 07, 2025

Arvinas (NASDAQ:ARVN) and Mustang Bio (NASDAQ:MBIO) Financial Contrast - Defense World

May 07, 2025

May 05, 2025

Geode Capital Management LLC Purchases 38,951 Shares of Mustang Bio, Inc. (NASDAQ:MBIO) - Defense World

May 05, 2025

May 02, 2025

Cell Therapy Market Growth Set to Surge Significantly during 2025 – 2032 - newstrail.com

May 02, 2025

Apr 28, 2025

Closing Bell Recap: Mustang Bio Inc (MBIO) Ends at 1.22, Reflecting a -1.61 Downturn - DWinneX

Apr 28, 2025

Apr 28, 2025

Mustang Bio stock plunges to 52-week low of $2.6 amid sharp decline - MSN

Apr 28, 2025

Apr 26, 2025

Mustang Bio stock plunges to 52-week low of $1.12 - Investing.com Australia

Apr 26, 2025

Apr 25, 2025

Mustang Bio stock plunges to 52-week low of $1.12 By Investing.com - Investing.com South Africa

Apr 25, 2025

Apr 25, 2025

Financial Analysis: Bio-Key International Inc (BKYI)’s Ratios Unveil Key Insights - DWinneX

Apr 25, 2025

Apr 25, 2025

Cell Therapy Market Future Path and Key Opportunities 2025 – 2032 - newstrail.com

Apr 25, 2025

Apr 24, 2025

Mustang Bio (MBIO) Sells Facility to AbbVie for $1 Million - GuruFocus

Apr 24, 2025

Apr 24, 2025

Mustang Bio Inc: Rising -98.18% from 52-Week Low, Can the Stock Stay Afloat? - investchronicle.com

Apr 24, 2025

Apr 24, 2025

Mustang Bio (MBIO) Regains Nasdaq Compliance - GuruFocus

Apr 24, 2025

Apr 24, 2025

Now Is The Time To Build A Position In Mustang Bio Inc (NASDAQ:MBIO) - Marketing Sentinel

Apr 24, 2025

Apr 24, 2025

What to expect from MBIO’s earnings report this quarter? - uspostnews.com

Apr 24, 2025

Apr 05, 2025

Mustang Bio stock hits 52-week low at $1.20 amid sharp decline - Investing.com Canada

Apr 05, 2025

Apr 04, 2025

Mustang Bio stock hits 52-week low at $1.20 amid sharp decline By Investing.com - Investing.com South Africa

Apr 04, 2025

Mar 31, 2025

Fortress Biotech Inc. (FBIO) reports earnings - Quartz

Mar 31, 2025

Mar 28, 2025

Mustang Bio Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 28, 2025

Mar 28, 2025

Mustang Bio Inc. (MBIO) reports earnings - Quartz

Mar 28, 2025

Mar 28, 2025

MUSTANG BIO, INC. SEC 10-K Report - TradingView

Mar 28, 2025

Mar 25, 2025

Mustang Bio stock plunges to 52-week low of $1.35 By Investing.com - Investing.com Australia

Mar 25, 2025

Mar 25, 2025

Mustang Bio stock plunges to 52-week low of $1.35 - Investing.com India

Mar 25, 2025

Mar 17, 2025

Fortress Biotech partners with Partex for AI-driven drug discovery - Investing.com

Mar 17, 2025

Mar 11, 2025

Car T Cell Therapy Market Demand, Statistics, Future Growth and Outlook 2025-2032 | Mustang Bio, Fate Therapeutics - openPR

Mar 11, 2025

Mar 10, 2025

Mustang Bio stock plunges to 52-week low of $1.43 By Investing.com - Investing.com Australia

Mar 10, 2025

Mar 10, 2025

Mustang Bio stock plunges to 52-week low of $1.43 - Investing.com India

Mar 10, 2025

Mar 06, 2025

Mustang Bio Stock Price, Quotes and Forecasts | NASDAQ:MBIO - Benzinga

Mar 06, 2025

Mar 06, 2025

Petri Dish: Biotech leaves Worcester; Novo Nordisk, Eli Lilly partnerships - The Business Journals

Mar 06, 2025

Mar 05, 2025

Mustang Bio Regains Nasdaq Compliance, Secures Position For Cell Therapy Advancements - Nasdaq

Mar 05, 2025

Mar 05, 2025

Mustang Bio meets Nasdaq’s equity listing requirements By Investing.com - Investing.com Canada

Mar 05, 2025

Mar 05, 2025

Mustang Bio meets Nasdaq’s equity listing requirements - Investing.com India

Mar 05, 2025

Mar 05, 2025

Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement - The Manila Times

Mar 05, 2025

Mar 05, 2025

Mustang Bio, Inc. Regains Compliance with Nasdaq Capital Market Listing Requirements - Nasdaq

Mar 05, 2025

Mar 05, 2025

Mustang Bio Overcomes Delisting Threat: What This Nasdaq Compliance Means for Investors - StockTitan

Mar 05, 2025